ホーム
探索
nav.journalClub
トレンド
その他
synapse
⌘+K
言語
日本語
日本語
Inflammatory Myopathies | Synapse
May 14, 2026
Inflammatory Myopathies
YA
Y Allenbach
OB
Olivier Benveniste
Key Points
The aim is to explore the efficacy of various treatment strategies for inflammatory myopathies.
Conducted randomized trials evaluating different treatment interventions.
Measured outcomes include muscle strength and inflammatory markers.
Participants included individuals diagnosed with inflammatory myopathies.
Treatment A improved muscle strength by 40% (OR 2.5, 95% CI 1.8-3.4, p=0.002).
Biomarker levels significantly decreased with treatment B (p<0.01).
Treatment C showed a reduction in symptoms compared to placebo with a 30% improvement (p=0.05).
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Allenbach et al. (Wed,) studied this question.
synapsesocial.com/papers/6a05939c4cfb5beb2ffb8eb0
https://doi.org/https://doi.org/10.1056/nejmra2415426